Skip to main content
Premium Trial:

Request an Annual Quote

Arrayjet Inks Servicing Agreement with GMI Covering North America

NEW YORK (GenomeWeb News) – Microarray firm Arrayjet today announced it signed a service agreement with GMI to provide local service and support to Arrayjet's North America customer based.

Financial and other terms of the deal were not disclosed.

Edinburgh, UK-based Arrayjet said that North America is a key geography for the company, and with an expanding installed based "it was critical moving forward that the company could offer local service and support and has been keen to find a suitable partner."

GMI is headquartered in Ramsey, Minn. and provides laboratory instrumentation and instrument service solutions.

The deal follows an agreement between Arrayjet and Australian diagnostics and drug firm Agenix to jointly develop a point-of-care testing platform into a multiplex testing and screening system.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.